Skip to content
10-Q

Quarterly Report

JOUNCE THERAPEUTICS, INC.

0001640455-22-000103

← back to feed
Filed
Nov 10, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 7, 2022 51.69M sh
Shares Diluted Q3 2022 · Sep 30, 2022 51.69M sh
Shares Diluted Q3 2022 · Sep 30, 2022 51.67M sh
Shares Diluted Q3 2022 · Sep 30, 2021 51.23M sh
Shares Diluted Q3 2022 · Sep 30, 2021 49.49M sh
Capex Q3 2022 · Sep 30, 2022 $696K
Capex Q3 2022 · Sep 30, 2021 $247K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$88.11M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$55.29M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $77.11M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $95.53M
Cash And Equivalents Q3 2022 · Sep 30, 2021 $145.37M
Cash And Equivalents Q3 2022 · Dec 31, 2020 $147.49M
Stockholders Equity Q3 2022 · Sep 30, 2022 $129.36M
Stockholders Equity Q3 2022 · Jun 30, 2022 $157.73M
Stockholders Equity Q3 2022 · Mar 31, 2022 $188.96M
Stockholders Equity Q3 2022 · Dec 31, 2021 $223.81M
Stockholders Equity Q3 2022 · Sep 30, 2021 $251.37M
Stockholders Equity Q3 2022 · Jun 30, 2021 $278.46M
Stockholders Equity Q3 2022 · Mar 31, 2021 $279.45M
Stockholders Equity Q3 2022 · Dec 31, 2020 $211.29M
Current Liabilities Q3 2022 · Sep 30, 2022 $21.8M
Current Liabilities Q3 2022 · Dec 31, 2021 $18.9M
Total Liabilities Q3 2022 · Sep 30, 2022 $28.72M
Total Liabilities Q3 2022 · Dec 31, 2021 $28.89M
Current Assets Q3 2022 · Sep 30, 2022 $139.93M
Current Assets Q3 2022 · Dec 31, 2021 $190.83M
Total Assets Q3 2022 · Sep 30, 2022 $158.08M
Total Assets Q3 2022 · Dec 31, 2021 $252.7M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.60
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.97
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.59
Eps Diluted Q3 2022 · Sep 30, 2021 −$1.23
Eps Basic Q3 2022 · Sep 30, 2022 −$0.60
Eps Basic Q3 2022 · Sep 30, 2022 −$1.97
Eps Basic Q3 2022 · Sep 30, 2021 −$0.59
Eps Basic Q3 2022 · Sep 30, 2021 −$1.23
Sga Expense Q3 2022 · Sep 30, 2022 $7.65M
Sga Expense Q3 2022 · Sep 30, 2022 $22.51M
Sga Expense Q3 2022 · Sep 30, 2021 $6.85M
Sga Expense Q3 2022 · Sep 30, 2021 $21.79M
Rd Expense Q3 2022 · Sep 30, 2022 $23.75M
Rd Expense Q3 2022 · Sep 30, 2022 $80.07M
Rd Expense Q3 2022 · Sep 30, 2021 $23.29M
Rd Expense Q3 2022 · Sep 30, 2021 $65.9M
Net Income Q3 2022 · Sep 30, 2022 −$31M
Net Income Q3 2022 · Sep 30, 2022 −$101.88M
Net Income Q3 2022 · Jun 30, 2022 −$33.51M
Net Income Q3 2022 · Mar 31, 2022 −$37.37M
Net Income Q3 2022 · Sep 30, 2021 −$30.09M
Net Income Q3 2022 · Sep 30, 2021 −$60.64M
Net Income Q3 2022 · Jun 30, 2021 −$4.01M
Net Income Q3 2022 · Mar 31, 2021 −$26.54M
Operating Income Q3 2022 · Sep 30, 2022 −$31.41M
Operating Income Q3 2022 · Sep 30, 2022 −$102.58M
Operating Income Q3 2022 · Sep 30, 2021 −$30.14M
Operating Income Q3 2022 · Sep 30, 2021 −$60.77M